The Bravecto class action lawsuit also states that in September 2018, the FDA issued an alert about the possible neurological events that are associated with medicines like Bravecto to treat fleas and ticks.
“Because Defendant failed to disclose the risks of Bravecto to consumers and misrepresented the safety of Bravecto, consumers would be reasonable in purchasing Bravecto to treat their pets in a safe manner,” the class action lawsuit notes. In addition, the defendant allegedly did not tell veterinarians about the possible safety issues that the drug posed to pets. Palmieri says that when she purchased the tablet, the packaging and materials enclosed therein did not state that neurological adverse reactions were possible when taking the pill. The plaintiff claims that she has spent “tens of thousands of dollars” treating Jake after he ingested Bravecto. In September of this year, he reportedly fell down a flight of stairs and broke his leg. Since he ingested the drug, Jake has continued to have neurological episodes, according to the Bravecto class action lawsuit. The plaintiff states that she refused to release her claims as she wasn’t sure if Jake’s symptoms would be long-term and was still not sure if her dog’s symptoms were caused by the drug.Īfter more tests and a trip to a neurologist, the plaintiff’s veterinarian allegedly told her that he “presumed” that Jake’s diagnosis of meningitis was a result of “Bravecto toxicity,” which was contrary to what she was told by the defendant.
However, the company would only pay if she signed an agreement which would release any claims against the company, according to the Bravecto class action lawsuit. The company allegedly denied that that Jake’s sickness was caused by Bravecto but offered to pay for the emergency room visit.
Palmieri claims that she contacted Merck to talk about Jake’s possible adverse reaction to taking the drug.
0 kommentar(er)
